Non-hodgkin Lymphoma Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Non-hodgkin Lymphoma Genomics

- Cancer PHGKB -

What's New

Last Posted: Sep 14, 2017

---

• Serum polychlorinated biphenyls and leukocyte telomere length in a highly-exposed population: The Anniston Community Health Survey.  
  Callahan Catherine L et al. Environment international 2017 Sep 108212-220
• Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome.  
  Samadder N Jewel et al. JAMA oncology 2017 Aug
• BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab.  
  Huet Sarah et al. American journal of hematology 2017 Jun 92(6) 515-519
• Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell of origin-specific clinical impact.  
  Ennishi Daisuke et al. Blood 2017 Mar
• Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study.  
  Zöller Bengt et al. Thrombosis research 2015 Sep 136(3) 573-81
• Familial Risk in Patients With Carcinoma of Unknown Primary.  
  Samadder N Jewel et al. JAMA oncology 2015 Dec 1-7
• Recurrent genomic rearrangements in primary testicular lymphoma.  
  Twa David D W et al. J. Pathol. 2015 Jun (2) 136-41
• LymphomiRs: microRNAs with regulatory roles in lymphomas.  
  Kozloski Goldi A et al. Curr. Opin. Hematol. 2015 Jul (4) 362-8
• Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations.  
  Bassig Bryan A et al. Eur. J. Haematol. 2015 Jan 22.
• Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.  
  Skibola Christine F et al. Am. J. Hum. Genet. 2014 Oct 2. (4) 462-71